Biostatistical methodology in carcinogenicity studies

Show simple item record

dc.identifier.uri http://dx.doi.org/10.15488/2987
dc.identifier.uri http://www.repo.uni-hannover.de/handle/123456789/3017
dc.contributor.author Fairweather, William R.
dc.contributor.author Bhattacharyya, Amit
dc.contributor.author Ceuppens, Peter P.
dc.contributor.author Heimann, Günter
dc.contributor.author Hothorn, Ludwig A.
dc.contributor.author Kodell, Ralph L.
dc.contributor.author Lin, Karl K.
dc.contributor.author Mager, Harry
dc.contributor.author Middleton, Brian J.
dc.contributor.author Slob, Wout
dc.contributor.author Soper, Keith A.
dc.contributor.author Stallard, Nigel
dc.contributor.author Ventre, John
dc.contributor.author Wright, Jane
dc.date.accessioned 2018-02-28T13:27:47Z
dc.date.available 2018-02-28T13:27:47Z
dc.date.issued 1998
dc.identifier.citation Fairweather, W.R.; Bhattacharyya, A.; Ceuppens, P.P.; Heimann, G.; Hothorn, L.A. et al.: Biostatistical methodology in carcinogenicity studies. In: Therapeutic Innovation & Regulatory Science 32 (1998), Nr. 2, S. 401-421. DOI: https://doi.org/10.1177/009286159803200212
dc.description.abstract This paper addresses the design, conduct, and statistical analysis of carcinogenicity studies, especially in the context of drug products for human use. It contains suggestions concerning the choice of dose levels, number of animals, methods of slide reading, and the ensuing statistical analysis, focusing on the significance testing approach. The purpose of this document is to describe the current thinking of statisticians and others who work in the area of carcinogenicity studies. The authors represent experience gained in the pharmaceutical industry, regulatory agencies, and academia. © 1998, Drug Information Association. All rights reserved. eng
dc.language.iso eng
dc.publisher London : SAGE Publications Ltd.
dc.relation.ispartofseries Therapeutic Innovation & Regulatory Science 32 (1998), Nr. 2
dc.rights Es gilt deutsches Urheberrecht. Das Dokument darf zum eigenen Gebrauch kostenfrei genutzt, aber nicht im Internet bereitgestellt oder an Außenstehende weitergegeben werden. Dieser Beitrag ist aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.
dc.subject Carcinogenicity eng
dc.subject Data analysis eng
dc.subject Literature eng
dc.subject Study design eng
dc.subject Test statistics eng
dc.subject.ddc 610 | Medizin, Gesundheit ger
dc.title Biostatistical methodology in carcinogenicity studies eng
dc.type article
dc.type Text
dc.relation.issn 2168-4790
dc.relation.doi https://doi.org/10.1177/009286159803200212
dc.bibliographicCitation.issue 2
dc.bibliographicCitation.volume 32
dc.bibliographicCitation.firstPage 401
dc.bibliographicCitation.lastPage 421
dc.description.version publishedVersion
tib.accessRights frei zug�nglich


Files in this item

This item appears in the following Collection(s):

Show simple item record

 

Search the repository


Browse

My Account

Usage Statistics